MARKET

ABBV

ABBV

Abbvie Inc
NYSE
250.82
+2.06
+0.83%
After Hours: 251.50 +0.68 +0.27% 19:40 08/13 EDT
OPEN
252.94
PREV CLOSE
248.76
HIGH
255.30
LOW
249.35
VOLUME
4.37M
TURNOVER
--
52 WEEK HIGH
267.47
52 WEEK LOW
189.65
MARKET CAP
443.23B
P/E (TTM)
70.94
1D
5D
1M
3M
1Y
5Y
1D
AbbVie Price Target Announced at $300.00/Share by Wolfe Research
Dow Jones · 6h ago
AbbVie Raised to Outperform From Peer Perform by Wolfe Research
Dow Jones · 6h ago
Wolfe Research Upgrades AbbVie to Outperform, Announces $300 Price Target
Benzinga · 6h ago
Pharma companies sour on Swiss drug applications amid Trump’s MFN policy
Seeking Alpha · 7h ago
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)
TipRanks · 7h ago
American Century Focused Global Growth Fund Q2 2026 Portfolio Review
Seeking Alpha · 15h ago
Did AbbVie’s Strong Q2, Higher 2026 Guidance, and New Approvals Just Shift AbbVie’s (ABBV) Investment Narrative?
Simply Wall St · 1d ago
AbbVie’s BOTOX Jawline Trial Wraps Up: What the Masseter Study Means for ABBV Investors
TipRanks · 1d ago
More
About ABBV
AbbVie Inc. is a global, diversified, research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Duodopa is a levodopa-carbidopa intestinal gel for the treatment of Parkinson's disease. Eye care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella.

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.